Physician profile
Amber Freeman
NPI 1780218123
$4,930.92
in general payments reported to CMS, 2019-2025
31 companies · $586 in 2025
The $586 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $1,141 · 2023: $1,375 · 2024: $1,541 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,502.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $820.30 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $809.34 | 2022-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $527.29 | 2022-2025 | Farxiga, Airsupra |
| Dexcom, INC. | $481.48 | 2021-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $328.92 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $323.91 | 2022-2025 | |
| Pfizer INC. | $211.87 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.86 | 2021-2024 | Jardiance, Tradjenta |
| Merck Sharp & Dohme LLC | $142.17 | 2021-2023 | Belsomra, Steglatro, Steglujan |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.42 | 2023-2024 | Xifaxan, Trulance |
| Exact Sciences Corporation | $108.00 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $96.78 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $79.74 | 2022-2025 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $77.46 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.07 | 2022-2025 | Trintellix |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $67.83 | 2024 | Repatha, Evenity, Prolia |
| Biohaven Pharmaceutical Holding Company LTD. | $57.97 | 2022 | |
| Janssen Pharmaceuticals, INC | $55.16 | 2023-2024 | Xarelto |
| Corcept Therapeutics | $50.86 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $48.14 | 2023-2025 | Rexulti |
| Baxter Healthcare | $44.50 | 2025 | Hillrom - Monarch Airway Clearance System |
| Eisai INC. | $36.80 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $32.11 | 2022-2023 | Quviviq |
| Phathom Pharmaceuticals, INC. | $30.57 | 2024 | Voquezna |
| Corium, LLC | $25.26 | 2024 | Azstarys |
| Ibsa Pharma INC. | $22.22 | 2025 | Licart, Tirosint, Flector |
| Astellas Pharma US INC | $21.20 | 2024 | Veozah |
| Impel Pharmaceuticals INC. | $17.87 | 2023 | Trudhesa |
| Mallinckrodt Hospital Products INC. | $15.05 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.55 | 2024 | Zoryve |
| Recordati_rare_diseases_inc. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.